AREN03B2 -- Renal Tumors Classification, Biology, and Banking Study
The purpose of this research study is to classify patients with renal tumors by histological categorization, surgico-pathological stage, presence of metastases, age at diagnosis, tumor weight, and loss of heterozygosity for chromosomes 1p and 16q, and to define eligibility for a series of therapeutic studies. Secondary objectives for the trial include:
- Monitor outcome for those patients who are not eligible for a subsequent therapeutic study.
- Describe whether the pulmonary tumor burden correlates with outcome in patients with stage IV disease.
- Correlate the method of conception (natural vs assisted reproductive technology) with the development of Wilms' tumor.
Eligibility
Patients may be eligible for this trial if:
- Patients must be < 30 years old at the time of diagnosis
- Patients with tumors of the following histologic type are eligible for this study:
- Nephroblastic tumors
- Nephroblastoma (Wilms' tumor) (favorable histology, anaplasia [diffuse, focal])
- Nephrogenic rests and nephroblastomatosis
- Cystic nephroma and cystic partially differentiated nephroblastoma
- Metanephric tumors (metanephric adenoma, metanephric adenofibroma, metanephric stromal tumor)
- Mesoblastic nephroma (cellular, classic, mixed)
- Clear cell sarcoma
- Rhabdoid tumor (any malignant rhabdoid tumor occurring outside the CNS)
- Renal epithelioid tumors of childhood (papillary renal cell carcinoma, medullary renal cell carcinoma, renal tumors associated with Xp11.2 translocations, oncocytic renal neoplasms after neuroblastoma)
- Angiolipoma
- Ossifying renal tumor of infancy
Trial Sponsor
- Children’s Oncology Group (COG); National Cancer Institute (NCI)
Project Begin Date
Tentative Project End Date
Back to Pediatric Hematology-Oncology Research